Trials / Completed
CompletedNCT03521180
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
Model Development, Clinical Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a model development, open label, no therapeutic treatment, three sequential group, short term-gluten challenge study in subjects with celiac disease. Immune responses are evaluated following gluten challenge. Approximately fifteen subjects with celiac disease will be enrolled in up to three sequential groups (5 subjects per group).
Conditions
Timeline
- Start date
- 2018-05-11
- Primary completion
- 2019-07-18
- Completion
- 2019-07-18
- First posted
- 2018-05-11
- Last updated
- 2020-02-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03521180. Inclusion in this directory is not an endorsement.